News

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...
In this week’s edition of InnovationRx, we look at Trump's drug pricing executive order, how the cofounder of Hims became a ...
SHANGHAI (Reuters) -Australia will "not compromise" on its policy to subsidise the cost of some medicines, the government ...
Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive ...
Trump spoke about a sweeping executive order he signed Monday that promised to lower prescription drug prices by between 59% ...
President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United States — but why are drugs so high to begin with?
Explore more
While Trump has not yet turned to price controls to address America‘s absurdly high drug prices, Monday‘s executive order ...
Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...
US President Donald Trump released an executive order on May 12 calling for a 30-day negotiation period between the ...
Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.
President Donald Trump's executive order on drug pricing could potentially jeopardize Roche's extensive $50 billion ...